New Direcetions in the Development of Pre-Filled Syringes
An increase in the number of viscous biopharm products reaching the
market, plus new requirements for absolute needle safety, is driving the
development of novel PFS/auto-injector combination devices.
By Bob Sharp and Paul Whyte at Future Injection Technologies (FIT) Ltd (March 2010)
Keywords: pre-filled syringes, viscous biopharm products, needle, PFS, auto-injector, regulatory, commercial, financial, suppliers